Hae Jin Suh Oh-rekin lankidetzan egindako argitalpenak (3)

2023

  1. Observational 24-week study to assess clinical response to upadacitinib posttrial in patients with moderate-to-severe atopic dermatitis

    JEADV Clinical Practice, Vol. 2, Núm. 3, pp. 571-575

2021

  1. Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry

    Journal of the European Academy of Dermatology and Venereology

  2. Primary cutaneous lymphomas in children: A prospective study from the Spanish Academy of Dermatology and Venereology (AEDV) Primary Cutaneous Lymphoma Registry

    Pediatric Dermatology, Vol. 38, Núm. 6, pp. 1506-1509